Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05047094 |
Title | A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC |
Recruitment | Recruiting |
Gender | both |
Phase | |
Variant Requirements | No |
Sponsors | Alpha Tau Medical LTD. |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ISR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Sharett institute, Hadassah University Hospital - Ein-Kerem | RECRUITING | Jerusalem | 91120 | Israel | Details | |
Sheba Medical Center | RECRUITING | Ramat Gan | Israel | Details | ||
Tel-Aviv Medical Center | NOT_YET_RECRUITING | Tel Aviv | Israel | Details |